Rigel Pharmaceuticals Net Long-Term Debt 2010-2025 | RIGL

Rigel Pharmaceuticals net long-term debt from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
Rigel Pharmaceuticals Annual Net Long-Term Debt
(Millions of US $)
2024 $N/A
2023 $20
2022 $20
2021 $N/A
2020 $10
2019 $10
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
2014 $N/A
2013 $N/A
2012 $N/A
2011 $-1
2010 $-1
2009 $-1
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.350B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $77.504B 29.07
Zoetis (ZTS) US $65.610B 24.48
Daiichi Sankyo, - (DSNKY) JP $46.052B 23.60
Takeda Pharmaceutical (TAK) JP $45.947B 9.14
BeOne Medicines - (ONC) KY $31.996B 0.00
Sandoz Group AG (SDZNY) CH $25.212B 0.00
Summit Therapeutics (SMMT) US $19.562B 0.00
Merck (MKKGY) DE $16.608B 12.17
Shionogi (SGIOY) JP $14.377B 14.40
United Therapeutics (UTHR) US $13.222B 11.70
Neurocrine Biosciences (NBIX) US $13.047B 44.69
Orion OYJ (ORINY) FI $10.973B 26.45
IPSEN (IPSEY) FR $10.477B 0.00
Corcept Therapeutics (CORT) US $7.436B 60.45
Madrigal Pharmaceuticals (MDGL) US $7.348B 0.00
Stevanato Group S.p.A (STVN) IT $7.320B 44.76
Grifols, S.A (GRFS) ES $6.876B 0.00
Ionis Pharmaceuticals (IONS) US $6.613B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $6.153B 0.00
Ono Pharmaceutical (OPHLF) JP $5.214B 15.86
Soleno Therapeutics (SLNO) US $4.383B 0.00
Procaps Group, S.A (PROCF) LU $3.202B 0.00
Hypermarcas (HYPMY) BR $3.004B 19.76
Crinetics Pharmaceuticals (CRNX) US $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.563B 8.98
NewAmsterdam Pharma (NAMS) NL $2.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.479B 13.41
Centessa Pharmaceuticals (CNTA) GB $2.145B 0.00
Ocular Therapeutix (OCUL) US $1.834B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.783B 0.00
ARS Pharmaceuticals (SPRY) US $1.753B 0.00
Endo (NDOI) US $1.656B 0.00
Harrow (HROW) US $1.360B 0.00
Guardian Pharmacy Services (GRDN) US $1.322B 0.00
Evotec AG (EVO) DE $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.165B 23.30
Enliven Therapeutics (ELVN) US $1.073B 0.00
Avadel Pharmaceuticals (AVDL) IE $1.062B 0.00
Ardelyx (ARDX) US $1.058B 0.00
Dyne Therapeutics (DYN) US $1.042B 0.00
Akebia Therapeutics (AKBA) US $1.009B 0.00
Collegium Pharmaceutical (COLL) US $0.993B 5.36
Verve Therapeutics (VERV) US $0.974B 0.00
ProKidney (PROK) US $0.942B 0.00
Cronos Group (CRON) CA $0.806B 0.00
Xeris Biopharma Holdings (XERS) US $0.804B 0.00
KalVista Pharmaceuticals (KALV) US $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.732B 0.00
Xencor (XNCR) US $0.648B 0.00
Zevra Therapeutics (ZVRA) US $0.641B 0.00
Relay Therapeutics (RLAY) US $0.622B 0.00
Organogenesis (ORGO) US $0.578B 0.00
Elite Pharmaceuticals (ELTP) US $0.569B 0.00
Theravance Biopharma (TBPH) US $0.568B 0.00
USANA Health Sciences (USNA) US $0.564B 12.26
Bioventus (BVS) US $0.518B 13.12
Oruka Therapeutics (ORKA) US $0.516B 0.00
Siga Technologies (SIGA) US $0.489B 10.22
Tourmaline Bio (TRML) US $0.468B 0.00
Aquestive Therapeutics (AQST) US $0.420B 0.00
Savara (SVRA) US $0.396B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.332B 0.00
Altimmune (ALT) US $0.328B 0.00
Aldeyra Therapeutics (ALDX) US $0.323B 0.00
Nektar Therapeutics (NKTR) US $0.308B 0.00
AleAnna (ANNA) US $0.300B 0.00
Heron Therapeutics (HRTX) US $0.293B 0.00
Nature's Sunshine Products (NATR) US $0.273B 25.08
OmniAb (OABI) US $0.242B 0.00
Nanobiotix S.A (NBTX) FR $0.241B 0.00
Esperion Therapeutics (ESPR) US $0.228B 0.00
MediWound (MDWD) IL $0.217B 0.00
Larimar Therapeutics (LRMR) US $0.209B 0.00
4D Molecular Therapeutics (FDMT) US $0.196B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.188B 0.00
Aclaris Therapeutics (ACRS) US $0.178B 0.00
Galectin Therapeutics (GALT) US $0.173B 0.00
Journey Medical (DERM) US $0.168B 0.00
Profound Medical (PROF) CA $0.167B 0.00
Liminatus Pharma (LIMN) US $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.141B 0.00
Inhibikase Therapeutics (IKT) US $0.140B 0.00
Avita Medical (RCEL) US $0.138B 0.00
Protara Therapeutics (TARA) US $0.132B 0.00
Lexeo Therapeutics (LXEO) US $0.131B 0.00
Korro Bio (KRRO) US $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.124B 0.00
Cassava Sciences (SAVA) US $0.111B 0.00
Champions Oncology (CSBR) US $0.111B 18.25
Innate Pharma SA (IPHYF) FR $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.105B 0.00
Cardiol Therapeutics (CRDL) CA $0.101B 0.00
VAXART, INC (VXRT) US $0.097B 0.00
Achieve Life Sciences (ACHV) CA $0.092B 0.00
Vivani Medical (VANI) US $0.092B 0.00
Nutriband (NTRB) US $0.092B 0.00
Fractyl Health (GUTS) US $0.088B 0.00
Wellgistics Health (WGRX) US $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.084B 0.00
ESSA Pharma (EPIX) CA $0.083B 0.00
Metagenomi (MGX) US $0.081B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Dominari Holdings (DOMH) US $0.076B 0.00
Surrozen (SRZN) US $0.074B 0.00
Rafael Holdings (RFL) US $0.074B 0.00
Avalo Therapeutics (AVTX) US $0.073B 0.00
Verrica Pharmaceuticals (VRCA) US $0.071B 0.00
Pyxis Oncology (PYXS) US $0.070B 0.00
PMV Pharmaceuticals (PMVP) US $0.070B 0.00
Assertio Holdings (ASRT) US $0.067B 0.00
Telomir Pharmaceuticals (TELO) US $0.066B 0.00
Inotiv (NOTV) US $0.059B 0.00
Jupiter Neurosciences (JUNS) US $0.059B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Unicycive Therapeutics (UNCY) US $0.057B 0.00
Klotho Neurosciences (KLTO) US $0.055B 0.00
ElectroCore (ECOR) US $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.052B 38.89
NRx Pharmaceuticals (NRXP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.050B 0.00
Prelude Therapeutics (PRLD) US $0.048B 0.00
Gain Therapeutics (GANX) US $0.048B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Mural Oncology (MURA) IE $0.043B 0.00
PolyPid (PYPD) IL $0.038B 0.00
Iterum Therapeutics (ITRM) IE $0.035B 0.00
Karyopharm Therapeutics (KPTI) US $0.035B 0.00
Vivos Therapeutics (VVOS) US $0.032B 0.00
FibroGen (FGEN) US $0.031B 0.00
Enlivex Therapeutics (ENLV) IL $0.028B 0.00
Scienture Holdings (SCNX) US $0.028B 0.00
SCYNEXIS (SCYX) US $0.028B 0.00
Incannex Healthcare (IXHL) AU $0.024B 0.00
Tempest Therapeutics (TPST) US $0.023B 0.00
Natural Alternatives (NAII) US $0.021B 0.00
Relmada Therapeutics (RLMD) US $0.020B 0.00
Plus Therapeutics (PSTV) US $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.019B 0.00
BioLineRx (BLRX) IL $0.019B 0.00
VYNE Therapeutics (VYNE) US $0.018B 0.00
DURECT (DRRX) US $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.017B 0.00
Lipocine (LPCN) US $0.017B 0.00
ProPhase Labs (PRPH) US $0.017B 0.00
Carisma Therapeutics (CARM) US $0.016B 0.00
Mannatech (MTEX) US $0.015B 0.00
Citius Pharmaceuticals (CTXR) US $0.015B 0.00
CASI Pharmaceuticals (CASI) CN $0.015B 0.00
Ernexa Therapeutics (ERNA) US $0.014B 0.00
Cosmos Health (COSM) US $0.014B 0.00
BioVie (BIVI) US $0.014B 0.00
Minerva Neurosciences (NERV) US $0.014B 2.37
TherapeuticsMD (TXMD) US $0.013B 0.00
Phio Pharmaceuticals (PHIO) US $0.011B 0.00
Ainos (AIMD) US $0.011B 0.00
Lyra Therapeutics (LYRA) US $0.011B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
Aptorum Group (APM) GB $0.009B 0.00
Traws Pharma (TRAW) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
NLS Pharmaceutics (NLSP) CH $0.008B 0.00
Nuvilex (PMCB) US $0.007B 0.00
Indaptus Therapeutics (INDP) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Xenetic Biosciences (XBIO) US $0.006B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Qualigen Therapeutics (QLGN) US $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.005B 0.00
SciSparc (SPRC) IL $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
SHINECO (SISI) CN $0.003B 0.00
CERo Therapeutics Holdings (CERO) US $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Heatwurx (PCSA) US $0.003B 0.00
Aditxt (ADTX) US $0.003B 0.00
Jaguar Animal Health (JAGX) US $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Indivior (INDV) US $0.000B 9.12
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00